harmonybiosciences.com (HRMY) Tezkor likvidlik koeffitsiyenti
Harmony Biosciences (HRMY) muvaffaqiyati Wakix retseptlari dinamikasi va FDA tomonidan yangi ko'rsatmalarning tasdiqlanishiga asoslangan. Aktivlarini diversifikatsiya qilish uchun kompaniya faol ravishda startaplar va litsenziyalarni sotib olmoqda, bu esa bozor narxi grafigida aks etgan bo'lib, u yerda joriy ko'rsatkich 3.42 ni tashkil etadi. Yuqori masshtablashish salohiyati uyqu buzilishlarini davolash vositalarining ishlab chiqilishi bilan bog'liq bo'lib, u yerda patentlangan dori vositalarining minimal ishlab chiqarish xarajatlari sezilarli daromadlar keltirmoqda.
%20Oraliq%20qoplash%20koeffitsiyenti&width=1200&height=400&colorIndex=0&v=mvujvhid.si-7ayy9s0&start=20220704&end=20261030&filename=GURU_Markets_-_HRMY_-_Harmony-Biosciences_-_Intermediate-Coverage-Ratio "Harmony Biosciences Holdings, Inc. - HRMY Tezkor likvidlik koeffitsiyenti (davr: 04.07.2022 - 30.10.2026) | 👁️GURU.Markets👁️")
harmonybiosciences.com (HRMY) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti
- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi tafsilotlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Qarzning xususiy kapitalga nisbati Harmony Biosciences|HRMY - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Harmony Biosciences Holdings, Inc.|HRMY - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati Harmony Pharma|HRMY - Kompaniyaning uzoq muddatli qarzdorligi|Kompaniyaning qisqa muddatli majburiyatlari Harmony Biosciences|Tezkor likvidlik ko‘rsatkichi harmonybiosciences.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
Kompaniyaning har tomonlama tahlili:Harmony Biosciences
Ushbu ko'rsatkich kompaniyaning sekin harakatlanuvchi zaxiralarga tayanmasdan, faqat naqd pul va debitorlik qarzlarga e'tibor qaratgan holda joriy majburiyatlarni to'lash qobiliyatini o'lchaydi. Modeli patentlangan dori vositalarining yuqori masshtablanuvchanligiga asoslangan Harmony Biosciences (HRMY) uchun tezkor koeffitsient qimmatbaho klinik sinovlarning yakunlanishi va daromadli bosqichga o'tishdan keyingi kapitalni boshqarish samaradorligini namoyish etadi.
Muhim raqobatchilar
Biogen Corp (BIIB) - Tezkor likvidlik|Shoshilinch likvidlik Neurocrine Corp (NBIX)|RGC (Regencell Bioscience) - Tezkor likvidlik koeffitsiyenti|AXSM: Oraliq qoplash koeffitsiyenti|Tezkor likvidlik koeffitsiyenti ACAD|Tezkor likvidlik koeffitsiyenti Xenon Pharmaceuticals Inc. (XENE)|Tezkor likvidlik Viking Pharma VKTX|Oraliq qoplash koeffitsiyenti SUPN|CPRX - Tezkor likvidlik|denalitherapeutics.com (DNLI) - Tezkor likvidlik ko‘rsatkichi|Biohaven (BHVN) - Tezkor likvidlik|Shoshilinch likvidlik Amylyx Pharmaceuticals Inc (AMLX)|Tezkor likvidlik Trevi Pharma|Shoshilinch likvidlik koeffitsiyenti PRAX (Praxis Corp)|Tezkor likvidlik ko‘rsatkichi AVXL (Anavex Life Sciences)|CBLL - Shoshilinch likvidlik|Prothena Corporation PLC - Tezkor likvidlik ko‘rsatkichi|Oraliq qoplash koeffitsiyenti ALEC|Annexon Inc. - Tezkor likvidlik koeffitsiyenti|OMER: Tezkor likvidlik|NGNE: Tezkor likvidlik koeffitsiyenti|ACIU - Oraliq qoplama koeffitsiyenti|Tezkor likvidlik Voyager Therapeutics, Inc.|Shoshilinch likvidlik Neumora NMRA|Tezkor likvidlik Scilex Holding Co. (SCLX)|Oraliq qoplama koeffitsiyenti Tevogen Bio Inc.|Tezkor likvidlik koeffitsiyenti ACOG (Alpha Cognition Inc.)|CGTX - Tezkor likvidlik ko‘rsatkichi|Inhibikase Therapeutics, Inc. - Tezkor likvidlik koeffitsiyenti|Oraliq qoplama koeffitsiyenti Cassava Sciences Inc SAVA|ASRT: Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik Coya Therapeutics (COYA)|Tezkor likvidlik VistaGen Therapeutics, Inc.|Shoshilinch likvidlik koeffitsiyenti OVID (Ovid Rx)|Tezkor likvidlik koeffitsiyenti ABOS|Tezkor likvidlik ko‘rsatkichi CervoMed, Inc. CRVO|Tezkor likvidlik koeffitsiyenti ATHE (Alterity Therapeutics Limited)|Clene Inc (CLNN) - Shoshilinch likvidlik|PEPG - Tezkor likvidlik|Oraliq qoplama koeffitsiyenti Jupiter Neurosciences, Inc. JUNS|RLMD: Tezkor likvidlik koeffitsiyenti|Annovis Bio Inc - Oraliq qoplash koeffitsiyenti|Tezkor likvidlik Grace Therapeutics Inc|AIFF: Oraliq qoplash koeffitsiyenti|Tezkor likvidlik Klotho Neurosciences Inc (KLTO)|Tezkor likvidlik ko‘rsatkichi neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings, Inc. - Tezkor likvidlik ko‘rsatkichi|MetaVia Inc. (MTVA) - Shoshilinch likvidlik|NRXS - Tezkor likvidlik|HSDT (Helius Medical) - Shoshilinch likvidlik koeffitsiyenti|PASG: Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik Neuphoria Therapeutics (NEUP)|Tezkor likvidlik ko‘rsatkichi NERV|Tezkor likvidlik koeffitsiyenti Athira Pharma Inc|Tezkor likvidlik Addex Therapeutics, Ltd. (ADXN)|ALZN (alzamend.com) - Oraliq qoplash koeffitsiyenti|Tezkor likvidlik Cyclerion Therapeutics, Inc. CYCN|Protagenic Therapeutics Inc. (PTIX) - Shoshilinch likvidlik|Pasithea - Tezkor likvidlik koeffitsiyenti|Oraliq qoplash koeffitsiyenti CRGT (Cortigent, Inc.)|ATXI: Tezkor likvidlik koeffitsiyenti|BrainStorm Cell Therapeutics Inc. (BCLI) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik Cara Therapeutics, Inc.|CHRO: Oraliq qoplash koeffitsiyenti|Tezkor likvidlik Eliem Therapeutics (ELYM)|Tezkor likvidlik ko‘rsatkichi intracellulartherapies.com ITCI|Tezkor likvidlik Longboard Pharma LBPH|Marinus Pharma (MRNS) - Shoshilinch likvidlik|NKGN - Tezkor likvidlik|NRBO (neurobopharma.com) - Shoshilinch likvidlik koeffitsiyenti|SAGE (Sage Therapeutics) - Tezkor likvidlik ko‘rsatkichi|Shoshilinch likvidlik Synaptogenix Inc. (SNPX)|Tezkor likvidlik ko‘rsatkichi TRVN|VIGL: Oraliq qoplash koeffitsiyenti|Tezkor likvidlik koeffitsiyenti WENA|Tezkor likvidlik CERE (cerevel.com)